ORR

Militia Long/Short Equity ETF

Investor Moves

NameValueActionChangePriceLast Price
Ken GriffinCitadel Advisors
$-487.2K
ExitQ4 2025
$487k
--
$36.32
Ken GriffinCitadel Advisors
$-487.2K
ExitQ4 2025
$487k
--
$36.32
Ken GriffinCitadel Advisors
$265.2K
AddQ3 2025
$265k
--
$36.32
Ken GriffinCitadel Advisors
$265.2K
AddQ3 2025
$265k
--
$36.32
Ken GriffinCitadel Advisors
$-37.8K
TrimQ2 2025
$38k
--
$36.32
Ken GriffinCitadel Advisors
$-37.8K
TrimQ2 2025
$38k
--
$36.32

News

gurufocus.comGenmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)gurufocus.comJun 13gurufocus.comNew TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myelgurufocus.comJun 13gurufocus.comBeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefitgurufocus.comJun 11gurufocus.comIDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Lategurufocus.comJun 1seekingalpha.comORR: A Long/Short Hedge Fund Disguised As An ETFseekingalpha.comJun 1